行情

DBVT

DBVT

DBV Tech
NASDAQ

实时行情|Nasdaq Last Sale

7.45
+0.07
+0.95%
已收盘, 16:05 11/20 EST
开盘
7.31
昨收
7.38
最高
7.60
最低
7.31
成交量
25.88万
成交额
--
52周最高
16.19
52周最低
3.600
市值
5.38亿
市盈率(TTM)
-2.2891
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

DBVT 新闻

  • 被通用汽车指控行贿 菲亚特克莱斯勒:毫无根据
  • 澎湃新闻.21分钟前
  • 拼多多股价大跌23% 创始人黄峥一夜之间损失48亿美元
  • 新浪科技.23分钟前
  • 英国大选已无悬念?市场预期保守党将轻松获胜
  • 环球外汇网官网.25分钟前
  • 沪指低开震荡 美联储称无意调整利率路径
  • 新浪财经.35分钟前

更多

所属板块

制药
-0.37%
制药与医学研究
-0.14%

热门股票

名称
价格
涨跌幅

DBVT 简况

DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.
展开

Webull提供DBV Technologies SA的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。